BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19669947)

  • 1. Macro role(s) of microRNAs in fragile X syndrome?
    Li X; Jin P
    Neuromolecular Med; 2009; 11(3):200-7. PubMed ID: 19669947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The state of synapses in fragile X syndrome.
    Pfeiffer BE; Huber KM
    Neuroscientist; 2009 Oct; 15(5):549-67. PubMed ID: 19325170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNAs and Fragile X Syndrome.
    Lin SL
    Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of messenger RNAs and microRNAs associated with fragile X mental retardation protein.
    Duan R; Jin P
    Methods Mol Biol; 2006; 342():267-76. PubMed ID: 16957381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microRNA pathway and fragile X mental retardation protein.
    Li Y; Lin L; Jin P
    Biochim Biophys Acta; 2008 Nov; 1779(11):702-5. PubMed ID: 18687414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A MicroRNA Profile in Fmr1 Knockout Mice Reveals MicroRNA Expression Alterations with Possible Roles in Fragile X Syndrome.
    Liu T; Wan RP; Tang LJ; Liu SJ; Li HJ; Zhao QH; Liao WP; Sun XF; Yi YH; Long YS
    Mol Neurobiol; 2015; 51(3):1053-63. PubMed ID: 24906954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
    De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
    Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile X protein family member FXR1P is regulated by microRNAs.
    Cheever A; Blackwell E; Ceman S
    RNA; 2010 Aug; 16(8):1530-9. PubMed ID: 20519410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors.
    Nakamoto M; Nalavadi V; Epstein MP; Narayanan U; Bassell GJ; Warren ST
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15537-42. PubMed ID: 17881561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of microRNA pathway in mental retardation.
    Qurashi A; Chang S; Peng J
    ScientificWorldJournal; 2007 Nov; 7():146-54. PubMed ID: 17982588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X Syndrome: from molecular pathology to therapy.
    Maurin T; Zongaro S; Bardoni B
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():242-55. PubMed ID: 24462888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragile X mental retardation protein participates in non-coding RNA pathways.
    Li EH; Zhao X; Zhang C; Liu W
    Yi Chuan; 2018 Feb; 40(2):87-94. PubMed ID: 29428901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing our understanding of human cognition through the study of Fragile X Syndrome.
    Cook D; Nuro E; Murai KK
    Dev Neurobiol; 2014 Feb; 74(2):147-77. PubMed ID: 23723176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction.
    Prieto M; Folci A; Martin S
    Mol Psychiatry; 2020 Aug; 25(8):1688-1703. PubMed ID: 31822816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms regulating the defects in fragile X syndrome neurons derived from human pluripotent stem cells.
    Halevy T; Czech C; Benvenisty N
    Stem Cell Reports; 2015 Jan; 4(1):37-46. PubMed ID: 25483109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of fragile X mental retardation protein in major mental disorders.
    Fatemi SH; Folsom TD
    Neuropharmacology; 2011 Jun; 60(7-8):1221-6. PubMed ID: 21108954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The translation of translational control by FMRP: therapeutic targets for FXS.
    Darnell JC; Klann E
    Nat Neurosci; 2013 Nov; 16(11):1530-6. PubMed ID: 23584741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic vesicle dynamic changes in a model of fragile X.
    Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
    Mol Autism; 2016; 7():17. PubMed ID: 26933487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.
    Bassell GJ; Warren ST
    Neuron; 2008 Oct; 60(2):201-14. PubMed ID: 18957214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.